Evvy, a women’s health startup, has launched an at-home test for urinary tract infection (UTI), the company announced Tuesday.

New York City-based Evvy is a direct-to-consumer company. Its flagship product is an at-home vaginal microbiome test, which checks for bacteria and fungi (or microbes) in people’s vaginas. Its new UTI+ Test is a urine test that leverages polymerase chain reaction (PCR) technology to detect 12 uropathogens and seven antibiotic-resistance genes.

Users collect their urine sample and then send it to Evvy’s lab. The company then provides results in one business day, and an Evvy clinician can offer same-day prescription pickup. Since the test determines both the specific pathogen and the resistance markers of the infection, it makes it easier for the provider to id

See Full Page